<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31693481</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-201X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>105</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Heart (British Cardiac Society)</Title>
          <ISOAbbreviation>Heart</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Peripartum cardiomyopathy: disease or syndrome?</ArticleTitle>
        <Pagination>
          <StartPage>357</StartPage>
          <EndPage>362</EndPage>
          <MedlinePgn>357-362</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/heartjnl-2018-314252</ELocationID>
        <Abstract>
          <AbstractText>Peripartum cardiomyopathy (PPCM) is a rare form of pregnancy-associated heart failure and is considered to be a diagnosis of exclusion. There are many hypotheses on the aetiology of PPCM; however, the exact pathophysiological mechanism remains unknown. It shows many resemblances to other conditions, such as familial dilated cardiomyopathy or myocarditis, and therefore it can be hard to make a definite diagnosis. We describe four cases of peripartum-onset heart failure in women who were suspected of having PPCM. We discuss the differential diagnosis, pathophysiological mechanisms and various diagnostic modalities.</AbstractText>
          <CopyrightInformation>© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Baris</LastName>
            <ForeName>Lucia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cornette</LastName>
            <ForeName>Jérôme</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, Erasmus MC, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Johnson</LastName>
            <ForeName>Mark R</ForeName>
            <Initials>MR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynaecology and Obstetric Medicine, Imperial College London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sliwa</LastName>
            <ForeName>Karen</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Hatter Institute for Cardiovascular Research in Africa, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roos-Hesselink</LastName>
            <ForeName>Jolien W</ForeName>
            <Initials>JW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>02</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Heart</MedlineTA>
        <NlmUniqueID>9602087</NlmUniqueID>
        <ISSNLinking>1355-6037</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Heart. 2019 Jul;105(13):1047</RefSource>
          <PMID Version="1">31201262</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Heart. 2019 Jul;105(13):1047-1048</RefSource>
          <PMID Version="1">31201263</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058725" MajorTopicYN="N">Peripartum Period</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011644" MajorTopicYN="N">Puerperal Disorders</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">familial cardiomyopathies</Keyword>
        <Keyword MajorTopicYN="Y">heart failure</Keyword>
        <Keyword MajorTopicYN="Y">idiopathic dilated cardiomyopathy</Keyword>
        <Keyword MajorTopicYN="Y">pregnancy</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31693481</ArticleId>
        <ArticleId IdType="pmc">PMC6613742</ArticleId>
        <ArticleId IdType="doi">10.1136/heartjnl-2018-314252</ArticleId>
        <ArticleId IdType="pii">heartjnl-2018-314252</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Sliwa K, Petrie MC, Hilfiker-Kleiner D, et al. . 
Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the heart failure association of the european society of cardiology study group on peripartum cardiomyopathy. Eur J Heart Fail 2018;20951–62. 10.1002/ejhf.1178</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.1178</ArticleId>
            <ArticleId IdType="pubmed">29578284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D, Sliwa K. 
Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol 2014;11:364–70. 10.1038/nrcardio.2014.37</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrcardio.2014.37</ArticleId>
            <ArticleId IdType="pubmed">24686946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pearson GD, Veille JC, Rahimtoola S, et al. . 
Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10703781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. . 
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: A position statement from the heart failure association of the european society of cardiology working group on peripartum cardiomyopathy. Eur J Heart Fail 2010;12:767–78. 10.1093/eurjhf/hfq120</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurjhf/hfq120</ArticleId>
            <ArticleId IdType="pubmed">20675664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel PA, Roy A, Javid R, et al. . 
A contemporary review of peripartum cardiomyopathy. Clin Med 2017;17:316–21. 10.7861/clinmedicine.17-4-316</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7861/clinmedicine.17-4-316</ArticleId>
            <ArticleId IdType="pmc">PMC6297639</ArticleId>
            <ArticleId IdType="pubmed">28765406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D, Haghikia A, Masuko D, et al. . 
Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy. Eur J Heart Fail 2017;19:1723–8. 10.1002/ejhf.808</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.808</ArticleId>
            <ArticleId IdType="pubmed">28345302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hall D, New D, Kelly T. 
Postpartum dilated cardiomyopathy in a patient with systemic lupus erythematosus, nephritis and lupus anticoagulant: a diagnostic dilemma. Obstet Med 2011;4:117–9. 10.1258/om.2011.100063</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1258/om.2011.100063</ArticleId>
            <ArticleId IdType="pmc">PMC4989601</ArticleId>
            <ArticleId IdType="pubmed">27579105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blavnsfeldt A, Høyer S, Mølgaard H, et al. . 
Severe acute and reversible heart failure shortly after childbirth: systemic lupus erythematosus or peripartum cardiomyopathy? Scand J Rheumatol 2015;44:83–4. 10.3109/03009742.2014.943805</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/03009742.2014.943805</ArticleId>
            <ArticleId IdType="pubmed">25558951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meyers DE, Basha HI, Koenig MK. 
Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management. Tex Heart Inst J 2013;40:385–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3783139</ArticleId>
            <ArticleId IdType="pubmed">24082366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor M, Graw S, Sinagra G, et al. . 
Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation 2011;124:876–85. 10.1161/CIRCULATIONAHA.110.005405</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.005405</ArticleId>
            <ArticleId IdType="pmc">PMC3167235</ArticleId>
            <ArticleId IdType="pubmed">21810661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, et al. . 
Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J 2014;35:2165–73. 10.1093/eurheartj/ehu050</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehu050</ArticleId>
            <ArticleId IdType="pubmed">24558114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mebazaa A, Seronde MF, Gayat E, et al. . 
Imbalanced angiogenesis in peripartum cardiomyopathy-diagnostic value of placenta growth factor. Circ J 2017;81:1654–61. 10.1253/circj.CJ-16-1193</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1253/circj.CJ-16-1193</ArticleId>
            <ArticleId IdType="pubmed">28552862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bello NA, Arany Z. 
Molecular mechanisms of peripartum cardiomyopathy: A vascular/hormonal hypothesis. Trends Cardiovasc Med 2015;25:499–504. 10.1016/j.tcm.2015.01.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcm.2015.01.004</ArticleId>
            <ArticleId IdType="pmc">PMC4797326</ArticleId>
            <ArticleId IdType="pubmed">25697684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ky B, French B, Ruparel K, et al. . 
The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure. J Am Coll Cardiol 2011;58:386–94. 10.1016/j.jacc.2011.03.032</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2011.03.032</ArticleId>
            <ArticleId IdType="pmc">PMC3193932</ArticleId>
            <ArticleId IdType="pubmed">21757116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts JM, Rajakumar A. 
Preeclampsia and soluble fms-like tyrosine kinase 1. J Clin Endocrinol Metab 2009;94:2252–4. 10.1210/jc.2009-0945</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2009-0945</ArticleId>
            <ArticleId IdType="pmc">PMC2708948</ArticleId>
            <ArticleId IdType="pubmed">19584199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patten IS, Rana S, Shahul S, et al. . 
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012;485:333–8. 10.1038/nature11040</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11040</ArticleId>
            <ArticleId IdType="pmc">PMC3356917</ArticleId>
            <ArticleId IdType="pubmed">22596155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curtarelli G, Ferrari C. 
Cardiomegaly and heart failure in a patient with prolactin-secreting pituitary tumour. Thorax 1979;34:328–31. 10.1136/thx.34.3.328</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thx.34.3.328</ArticleId>
            <ArticleId IdType="pmc">PMC471069</ArticleId>
            <ArticleId IdType="pubmed">158231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haring R, Friedrich N, Völzke H, et al. . 
Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality. Eur Heart J 2014;35:1215–21. 10.1093/eurheartj/ehs233</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehs233</ArticleId>
            <ArticleId IdType="pubmed">22843444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parissis JT, Farmakis D, Fountoulaki K, et al. . 
Clinical and neurohormonal correlates and prognostic value of serum prolactin levels in patients with chronic heart failure. Eur J Heart Fail 2013;15:1122–30. 10.1093/eurjhf/hft070</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurjhf/hft070</ArticleId>
            <ArticleId IdType="pubmed">23639781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Limas CJ, Kroupis C, Haidaroglou A, et al. . 
Hyperprolactinaemia in patients with heart failure: clinical and immunogenetic correlations. Eur J Clin Invest 2002;32:74–8. 10.1046/j.1365-2362.2002.00924.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2362.2002.00924.x</ArticleId>
            <ArticleId IdType="pubmed">11895452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hopp L, Haider B, Iffy L. 
Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement. Int J Cardiol 1996;57:227–32. 10.1016/S0167-5273(96)02789-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0167-5273(96)02789-1</ArticleId>
            <ArticleId IdType="pubmed">9024910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arrigo M, Blet A, Mebazaa A. 
Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD. Eur Heart J 2017;38:2680–2. 10.1093/eurheartj/ehx428</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehx428</ArticleId>
            <ArticleId IdType="pubmed">28934838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franchi F, Lazzeri C, Barletta G, et al. . 
Centrally mediated effects of bromocriptine on cardiac sympathovagal balance. Hypertension 2001;38:123–9. 10.1161/01.HYP.38.1.123</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.HYP.38.1.123</ArticleId>
            <ArticleId IdType="pubmed">11463772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vital M, Lebert C, Reignier J, et al. . 
sulprostone-associated heart failure? A case report and analysis of the literature. Arch Gynecol Obstet 2013;288:1423–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23708393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Mebazaa A, Hilfiker-Kleiner D, et al. . 
Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational research programme in conjunction with the heart failure association of the european society of cardiology study group on PPCM. Eur J Heart Fail 2017;19:1131–41. 10.1002/ejhf.780</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.780</ArticleId>
            <ArticleId IdType="pubmed">28271625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, et al. . 
Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010;121:2169–75. 10.1161/CIRCULATIONAHA.109.929646</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.929646</ArticleId>
            <ArticleId IdType="pubmed">20458010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Citro R, Giudice R, Mirra M, et al. . 
Is Tako-tsubo syndrome in the postpartum period a clinical entity different from peripartum cardiomyopathy? J Cardiovasc Med 2013;14:568–75. 10.2459/JCM.0b013e32835f1a49</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2459/JCM.0b013e32835f1a49</ArticleId>
            <ArticleId IdType="pubmed">23519095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D, Haghikia A, Nonhoff J, et al. . 
Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 2015;36:1090–7. 10.1093/eurheartj/ehv009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehv009</ArticleId>
            <ArticleId IdType="pmc">PMC4422973</ArticleId>
            <ArticleId IdType="pubmed">25636745</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
